Sfoglia per AUTORE
PIOVESAN A
Collezione AOU Città della Salute di Torino

  

Items : 27

Tailored management of advanced thyroid cancer patients treated with lenvatinib or vandetanib: the role of a multimodal approach. in Endocrine / Endocrine. 2025 Feb;87(2):724-733. doi: 10.1007/s12020-024-04061-2. Epub 2024 Oct 2.
2025
AOU Città della Salute di Torino

Piovesan A; Roux A; Gruosso G; Migliore E; Vaccaro E; Ferrari M; Nervo A; Arvat E;

A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis. in Thyroid : official journal of the American Thyroid Association / Thyroid. 2023 Nov;33(11):1318-1326. doi: 10.1089/thy.2023.0052. Epub 2023 Oct 19.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Crescenzi A; Centanni M; Sparano C; Bruno R; Ceresini G; Spiazzi G; Magri F; Messuti I; Patrizio A; Antonelli A; Lombardi CP; Pontecorvi A; Chiofalo MG; Solaroli E; Pezzullo L; Rossi M; Pagano L; Retta F; Deandrea M; Massa M; Crocetti U; Aimaretti G; Gagliardi I; Samà MT; Zatelli MC; Piovesan A; Nervo A; Morelli S; Puxeddu E; et alii...

A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2023 Jul 14;108(8):1921-1928. doi: 10.1210/clinem/dgad075.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Porcelli T; Triggiani V; Castagna MG; Repaci A; Tumino D; Mian C; Crescenzi A; Pezzullo L; Sparano C; Bruno R; Magri F; Monti S; Centanni M; Solaroli E; Castello R; Ceresini G; Rossetto R; D'Amore A; Antonelli A; Puligheddu B; Fugazzola L; Deandrea M; Mele C; Samà MT; Massa M; Crocetti U; Nervo A; Piovesan A; Gagliardi I; et alii...

Immune-related thyroid dysfunctions during anti PD-1/PD-L1 inhibitors: new evidence from a single centre experience. in Clinical and experimental medicine / Clin Exp Med. 2023 Dec;23(8):4817-4824. doi: 10.1007/s10238-023-01082-5. Epub 2023 Apr 27.
2023
AOU Città della Salute di Torino

Piovesan A; Roux A; D'Angelo V; Basile S; Migliore E; Gruosso G; Ferrari M; Nervo A; Arvat E;

Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2023 May 8;14:1158474. doi: 10.3389/fendo.2023.1158474. eCollection 202
2023
AO Cuneo
AOU Città della Salute di Torino

Arvat E; Borretta G; Procopio M; Gianotti L; Castellano E; Piovesan A; Maiorino F; Pusterla A; Retta F; Craparo A; Nervo A; Barale M;

External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort. in Endocrine pathology / Endocr Pathol. 2022 Sep;33(3):359-370. doi: 10.1007/s12022-022-09719-z. Epub 2022 May 18.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Volante M; Piovesan A; Rossetto Giaccherino R; Brizzi MP; Retta F; Osella Abate S; Maletta F; Fissore J; Papotti M; Vissio E;

Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from (68)Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine Tumors. in Journal of nuclear medicine : official publication, Society of Nuclear Medicine / J Nucl Med. 2022 Jul;63(7):1014-1020. doi: 10.2967/jnumed.121.262652. Epub 2021 Nov 5.
2022
AOU Città della Salute di Torino

Abgral R; Filippi R; Piovesan A; Arvat E; Santi B; Gallio E; Rampado O; Grimaldi S; Liberini V; Thuillier P; Molinari F; Deandreis D;

Comparison between 2015 ATA guidelines and Italian Consensus for DTC management. A commented report. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2022 Feb;42(1):41-54. doi: 10.14639/0392-100X-N1572.
2022
ASL Città di Torino
ASL Torino 4
AOU Città della Salute di Torino

Palestini N; Succo G; Rossetto Giaccherino R; Freddi M; Piovesan A; Crosetti E; Arrigoni G;

Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective. in Cancer management and research / Cancer Manag Res. 2022 Oct 21;14:3047-3062. doi: 10.2147/CMAR.S340967. eCollection 2022.
2022
AOU Alessandria
AOU Città della Salute di Torino

Arvat E; Gallo M; Piovesan A; Retta F; Ragni A; Nervo A;

Interventional Radiology Approaches for Liver Metastases from Thyroid Cancer: A Case Series and Overview of the Literature. in Journal of gastrointestinal cancer / J Gastrointest Cancer. 2021 Sep;52(3):823-832. doi: 10.1007/s12029-021-00646-6. Epub 2021 May 17.
2021
AOU Alessandria
AOU Città della Salute di Torino

Arvat E; Gallo M; Gazzera C; Calandri M; Retta F; Nervo A; Ragni A; Piovesan A;

Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. in Journal of endocrinological investigation / J Endocrinol Invest. 2021 Oct;44(10):2139-2151. doi: 10.1007/s40618-020-01491-3. Epub 2021 Feb 17.
2021
AOU Città della Salute di Torino

Piovesan A; Minaldi E; Valerio L; Giani C; Molinaro E; Agate L; Ragni A; Prete A; Nervo A; Matrone A; Elisei R;

Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues. in Journal of endocrinological investigation / J Endocrinol Invest. 2021 Mar;44(3):403-419. doi: 10.1007/s40618-020-01374-7. Epub 2020 Aug 3.
2021
AOU Città della Salute di Torino

Deandreis D; Ricardi U; Gatti M; Liberini V; Piovesan A; Gallo M; Retta F; Ragni A; Nervo A; Arvat E;

Quality of Life during Treatment with Lenvatinib for Thyroid Cancer: The Patients' Perspective beyond the Medical Evaluation. in European thyroid journal / Eur Thyroid J. 2021 Mar;10(1):65-71. doi: 10.1159/000508186. Epub 2020 Jul 13.
2021
AOU Città della Salute di Torino

Arvat E; Gallo M; Migliore E; Marica V; Piovesan A; Ragni A; Nervo A;

Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. in Journal of endocrinological investigation / J Endocrinol Invest. 2021 Dec;44(12):2859. doi: 10.1007/s40618-021-01592-7.
2021
AOU Città della Salute di Torino

Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R;

Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Dec;168:103533. doi: 10.1016/j.critrevonc.2021.103533. Epub 2021 Nov 19
2021
AOU Alessandria
AOU Città della Salute di Torino

Arvat E; Gallo M; Biancone L; Manganaro M; Mella A; Piovesan A; Ragni A; Retta F; Nervo A;

Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). in Thyroid : official journal of the American Thyroid Association / Thyroid. 2021 Dec;31(12):1814-1821. doi: 10.1089/thy.2021.0248. Epub 2021 Oct 20.
2021
AO Ordine Mauriziano
AOU Città della Salute di Torino

Durante C; Castagna MG; Filetti S; Ferraro Petrillo U; Lombardi CP; Pezzullo L; Repaci A; Tumino D; Bruno R; Sparano C; Crescenzi A; Tallini G; Monzani F; Rossetto R; Spiazzi G; Monti S; Fugazzola L; Centanni M; Antonelli A; Torlontano M; Puligheddu B; Ceresini G; Deandrea M; Pagano L; Morelli S; Puxeddu E; Ragni A; Piovesan A; Gagliardi I; et alii...

Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy. in Hypertension research : official journal of the Japanese Society of Hypertension / Hypertens Res. 2020 Jun;43(6):500-510. doi: 10.1038/s41440-019-0339-y. Epub 2019 Oct 4.
2020
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino

Arvat E; Ghigo E; Veglio F; Pasini B; Morino M; Terzolo M; Aimaretti G; Papotti M; Mulatero P; Volante M; Borretta G; Orlandi F; Limone P; Deandreis D; Ciccone G; Giraudo G; Piovesan A; Reimondo G; Giordano R; La Grotta A; Pia A; Maletta F; Mistrangelo M; Migliore E; Tassone F; Burrello J; Parasiliti-Caprino M; Lucatello B; Lopez C; et alii...

Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem. in Thyroid : official journal of the American Thyroid Association / Thyroid. 2020 Feb;30(2):229-236. doi: 10.1089/thy.2019.0355. Epub 2020 Jan 28.
2020
AOU Città della Salute di Torino

Nervo A; Ragni A; Gallo M; Ferraris A; Fonio P; Piovesan A; Arvat E;

(68)Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients. in Frontiers in medicine / Front Med (Lausanne). 2021 Jan 26;7:601853. doi: 10.3389/fmed.2020.601853. eCollection 2020.
2020
AOU Città della Salute di Torino

Molinari F; Versari A; Fioroni F; Piovesan A; Ciuffreda L; Thuillier P; Dionisi B; Ceci F; De Santi B; Rampado O; Gallio E; Liberini V; Deandreis D;

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Sep;118:35-40. doi: 10.1016/j.ejca.2019.05.031. Epub 2019 Jul 9.
2019
AOU Città della Salute di Torino

Locati LD; Piovesan A; Durante C; Bregni M; Castagna MG; Zovato S; Giusti M; Ibrahim T; Puxeddu E; Fedele G; Pellegriti G; Rinaldi G; Giuffrida D; Verderame F; Bertolini F; Bergamini C; Nervo A; Grani G; Rizzati S; Morelli S; Puliafito I; Elisei R;

Lenvatinib in differentiated thyroid carcinoma: the Italian experience. in Future oncology (London, England) / Future Oncol. 2019 Aug;15(24s):1-2. doi: 10.2217/fon-2019-0179. Epub 2019 Aug 6.
2019
AOU Città della Salute di Torino

Piovesan A;

Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice. in Anticancer research / Anticancer Res. 2018 Mar;38(3):1643-1649. doi: 10.21873/anticanres.12396.
2018
AOU Città della Salute di Torino

Nervo A; Gallo M; Samà MT; Felicetti F; Alfano M; Migliore E; Marchisio F; Berardelli R; Arvat E; Piovesan A;

Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2017 Dec;17(12):1093-1098. doi: 10.1080/14737140.2017.1390432. Epub 2017
2017
AOU Città della Salute di Torino

Felicetti F; Nervo A; Piovesan A; Berardelli R; Marchisio F; Gallo M; Arvat E;

Clinical challenges with calcitonin-negative medullary thyroid carcinoma. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2016 Sep;142(9):2023-9. doi: 10.1007/s00432-016-2169-5. Epub 2016 Apr 28.
2016
AOU Città della Salute di Torino

Samà MT; Rossetto Giaccherino R; Gallo M; Felicetti F; Maletta F; Bonelli N; Piovesan A; Palestini N; Ghigo E; Arvat E; Samà MT; Rossetto Giaccherino R; Gallo M; Felicetti F; Maletta F; Bonelli N; Piovesan A; Palestini N; Ghigo E; Arvat E;

Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. in International journal of endocrinology / Int J Endocrinol. 2016;2016:2930414. doi: 10.1155/2016/2930414. Epub 2016 Sep 27.
2016
AO Ordine Mauriziano
AOU Città della Salute di Torino

Arvat E; Limone PP; Milla P; Orlandi F; Gallo M; Brignardello E; Pugliese M; Catalano MG; Boccuzzi G; Piovesan A;

Sorafenib treatment of radioiodine-refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center. in Endocrine / Endocrine. 2015 Aug;49(3):726-34. doi: 10.1007/s12020-014-0481-x. Epub 2014 Nov 21.
2015
AOU Città della Salute di Torino

Michelon F; Castiglione A; Felicetti F; Gallo M; Viansone AA; Nervo A; Zichi C; Ciccone G; Piovesan A; Arvat E;

Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012. in Thyroid : official journal of the American Thyroid Association / Thyroid. 2014 Nov;24(11):1600-6. doi: 10.1089/thy.2014.0004. Epub 2014 Sep 5.
2014
AOU Città della Salute di Torino

Brignardello E; Palestini N; Felicetti F; Castiglione A; Piovesan A; Gallo M; Freddi M; Ricardi U; Gasparri G; Ciccone G; Arvat E; Boccuzzi G;